The results demonstrated an increase in BTN2A2 expression in patients with GBM, LGG, CHOL, HNSC, KIRC, LIHC, KIRP, STAD, DLBC, PAAD, SARC, SKCM and THYM. This evidence concerns the gene BTN2A2 and glioblastoma.